Current Elizabeth Holmes Net Worth and Estimated Holdings
Elizabeth Holmes net worth is estimated in the low single-digit millions as of the latest public filings and media reports, a sharp decline from the multi-billion-dollar valuation once assigned to her during the Theranos peak. Most estimates focus on residual assets, potential litigation proceeds, and any equity or compensation tied to ventures after Theranos, while noting that her personal liquid net worth remains limited. The precise figure fluctuates based on asset valuations, legal settlements, and undisclosed holdings, but credible outlets consistently place her wealth far below the tens of billions once projected by investors and media. For a detailed breakdown of the Theranos collapse and its financial aftermath, see the overview at https://www.forbes.com/sites/alicewouters/2021/01/26/theranos-founder-elizabeth-holmes-has-been-charged-with-fraud/.
How Her Net Worth Changed After the Theranos Collapse
Her net worth dropped dramatically after Theranos was voided of its valuation, regulators revoked its blood-testing licenses, and investors faced major losses in what became one of the largest startup fraud cases in U.S. history. Court records, SEC actions, and media coverage trace how Holmes went from being celebrated as the youngest self-made female billionaire to facing criminal charges and a substantially reduced personal financial position. The shift illustrates how private company valuations, fraudulent claims, and legal outcomes can rapidly alter an individual's apparent wealth, even when the person retains some residual assets or future income rights. For additional context on the SEC's role, see the relevant page at https://www.sec.gov/litigation/litreleases/2022/lr24330.htm.
Major Companies, Ventures, and Financial Connections
Elizabeth Holmes founded Theranos in 2003 and built the company around a claimed revolutionary blood-testing technology that was later found to be inaccurate and misleading to investors and patients. After Theranos was dissolved and its assets wound down, Holmes has been associated with new ventures and advisory roles, though none have yet restored the scale of wealth or public valuation that Theranos once implied. Her financial profile now centers on any ongoing compensation, legal settlements, and private asset holdings rather than a large publicly traded stake in a single dominant company. For more on Theranos' corporate history and downfall, see https://www.forbes.com/sites/alicewouters/2021/01/26/theranos-founder-elizabeth-holmes-has-been-charged-with-fraud/.
Post-Theranos Ventures and Current Business Activities
Since the Theranos collapse, Holmes has explored new startup and technology projects, though details about funding, valuations, and her personal equity in any successor entities remain limited and largely undisclosed. Public records, news reports, and court filings indicate that her current business activities focus on smaller-scale ventures and advisory work rather than the high-profile health-tech platform that defined her earlier career. These newer efforts have not yet generated the level of public financial disclosure or market valuation that would significantly alter widely reported estimates of her net worth. For an official perspective on the legal outcomes, see https://www.sec.gov/litigation/litreleases/2022/lr24330.htm.
Key Financial Milestones, Rankings, and Public Records
Elizabeth Holmes was once ranked among the world's youngest self-made billionaires by Forbes and other lists, based on Theranos' private valuations that later proved to be built on inflated or false claims about its technology and business prospects. Following criminal fraud charges, civil settlements, and the voiding of Theranos' valuation, her public rankings and net worth estimates dropped sharply, and she no longer appears on major billionaire or wealthy-individual lists. Current financial data emphasizes court rulings, regulatory actions, and the winding down of Theranos